In one of the biggest damages verdicts ever imposed, jurors in a district court trial in Lafayette, La., ordered the Japanese company, Takeda
Pharmaceutical, to pay $6 billion in punitive damages on Monday after finding that the company had hidden the cancer risks of its drug, Actosa. The jury also ordered Takeda’s partner, Eli Lilly,
which once marketed the drug in the United States, to pay $3 billion.
Read the whole story at The New York Times »